Pavan Vaddady

Pavan Vaddady currently serves as the Executive Director of Quantitative Pharmacology & Pharmacometrics in Immuno/Oncology at Merck, a position held since March 2024. Additionally, Pavan is a member of the Board of Trustees for the International Society of Pharmacometrics and an Adjunct Professor at The University of Tennessee Health Science Center. Prior to these roles, Pavan held the position of Senior Director & Head of Pharmacometrics at Daiichi Sankyo, Inc. from May 2021 to March 2024 and progressed through various scientific roles at Merck from June 2011 to May 2021. Pavan’s academic background includes a Ph.D. in Pharmacometrics from The University of Tennessee Health Science Center, as well as an M.Pharmacy and B.Pharm (Hons.) from the Birla Institute of Technology and Science, Pilani.